Photo of Dr. Mohammad A. Nezami, MD

Dr. Nezami has designed a patented method of treating patients with Cancer successfully, including patients who have failed all other conventional methods.

Advertisement

Reviews of Dr. Nezami
Dr. Nezami

Have you seen this doctor?

We invite you to write a review about your experience with Dr. Nezami.


Videos of Dr. Nezami
Dr. Nezami

UPDATE Breast Cancer patient DAWN  

Dr. Nezami speaking at the IPT Integrative Cancer Conference in Texas.  

Dr.Nezami at the 41st annual cancer control society cancer convention 2013.  

Pacific Medical Center of Hope Patient testimonial SHANNON  

Pacific/Orange Coast Medical Center of Hope  

Patient testimonial, Natalie  

UPDATE on Chronic Lymphatic Patient Tom  

Valley Life KMPH FOX 26 interview with Dr.Nezami  

Valley Life KMPH FOX 26 interview with Dr.Nezami in September  

Offices of Dr. Nezami See Insurance
of Dr. Nezami

Advertisement

Pacific Medical Center of Hope  


Accepting New Patients?

Yes, Dr. Mohammad A. Nezami is accepting new patients at this office.



Address

1680 E. Herndon Avenue, Suite 102, Fresno, CA 93720

Office Hours

  Open Lunch Close
Mon
Tue
Wed
Thu
Fri

Office Details

Doctor Specialties Critical Care Medicine & Internal Medicine & Holistic Medicine & Family Medicine & Immunology
Accepting New Patients? Yes
Practice Specialty Family Medicine
Languages Spoken English, Farsi, Persian, Spanish

Orange Coast Medical Center of Hope  


Accepting New Patients?

Yes, Dr. Mohammad A. Nezami is accepting new patients at this office.



Address

496 Old Newport Boulevard, Suite 7, Newport Beach, CA 92663

Office Hours

  Open Lunch Close
Mon
Tue
Wed
Thu
Fri
Sat

Office Details

Doctor Specialties Family Medicine & Holistic Medicine
Accepting New Patients? Yes
Practice Specialty Family Medicine
Languages Spoken English, Farsi, Persian, Spanish
Sponsored

You Might Like

Recommended from around the web


Learn more about RevenueStripe...

Insurance Accepted  


Please contact the doctor’s office to inquire about insurance.

About Dr. Nezami
Dr. Nezami

Advertisement

Bio


http://www.allcancercare.com/about-us.html

Using new method of treating patients with cancer (MTET), a non-toxic therapy that enhances the patient response and prevent recurrence need to be standard, and mainstream. This integrative approach can correlate with better outcome. We predict that such approach will become available to everyone affected by cancer. Insurance companies willing to pay for such services and public can have a better access to the therapy in future.The public must be informed to make educated, responsible choices about their health, including prevention and treatment of cancer.Patients with cancer need to be treated individually in a program that is customized based on their specific genetics.

 

Dr. Nezami is a graduate of USC and UCSF residencies. He has functioned as a faculty during his training as well as invited presenter at society of teachers in Family medicine. He has been in practice for 20 years and currently is the president of Pacific Medical Center of Hope in California. He is promoting research in conventional and integrative oncology, in cutting edge. Dr Nezami serves as national and international speaker in oncology and epigenetic science.  He has been involved in many research projects and publications, presentations ( including Society of integrative oncology( SIO), American Association for Cancer Research ( AACR), Molecular Medicine Triconference, World Molecular Imaging( WMI), and World Pharmaceutical Congress, NCI-AACR, .... Author, Integrative Medicine, A Clinician Journal, as well as author and coauthor in oncology literature. (Surveillance in lymphoma, published 2006, Cancer Science 2015, JCT 2015, 2016, Precision medicine,.....). He has co authored  Weil’s " Textbook for Integrative Oncology" in 2014.

Dr. Nezami is an inventor and innovator and has designed a patented novel method of treating patients with advanced cancer, called Modified Multi Molecular Targeted Epigenetic Therapy (MTET). With this method, during the last 7 years, he has successfully treated many patients, mostly with advanced stage four cancer who had failed all other conventional methods. National Cancer Institute and all their related oncology consultants have confirmed this method of treating patients with cancer as novel and effective. Several cancer institutions, including MD Anderson cancer center and private oncology centers have already started investigating his method in either preclinical or clinical settings, showing "extra ordinary" results. Dr. Nezami has served as principal investigator by National Institute of Health ( NIH); for TACT trial and is currently involved both in research and publications( as coauthor) with National Cancer Institute (NCI) in the best case series of complimentary and alternative cancer therapies. He also functions as speaker and medical consultant for Caris Life Sciences ( Caris Oncology Laboratory) and provides scientific expert review at Journal of Cancer Therapy ( JCT), British Journal of Medicine and Medical Research, ( BJM) as well as serving as editorial board and peer review expert in multidisciplinary scientific journals such as Biology and Medicine, Science International, Journal of Advances in Medical and Pharmaceutical Sciences, Cancer Studies, Asian Journal of Medicine and Health, International journal of cancer and tumor, Biology and Medicine, Archivum Immunologiae Et Therapiae Experimentalis,...Due to his expertise in the area of epigenetic science and oncology , he has recently been honored to serve as the organizer and/or chair for several oncology conferences, such as ICOR ( International conference on Oncology and Radiology), key note speaker and board member for several international oncology conferences.( ex. Radiation oncology and anti cancer therapy, International Conference on Nuclear Medicine and radiation therapy,...)His main area of interest are integrative oncology and epigenetics. He currently teaches and consults other physicians and oncologists and is extensively involved in research and pursuing clinical trials in this field.

Specialties


Special Interests  


  • Cancer
  • Cancer Control
  • Cancer Immunotherapeutics
  • Cancer Stem Cells
  • Epigenetics
  • Holistic and Integrated Approach
  • Integrative Cancer Treatments

Education & Training  


Medical School


Sponsored

Languages Spoken  


  • English
  • Spanish (Mexico)
  • Farsi
  • Persian (Iran)
Sponsored
PowerInbox Icon

You Might Like

Recommended stories from around the web


    Learn more about RevenueStripe...

Daily Health Newsletter from MD.com


Enter your email to receive a daily roundup of health tips, news & more in your inbox, Mon‑Fri:


To browse examples of previous newsletters, click here.

PrivacyTerms